Clinical Trial Update: Study of Intravenous ZMA001 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating intravenous ZMA001 in healthy subjects to characterize safety, tolerability, and pharmacokinetics, with the trial listed under the cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• ZMA001

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Pulmonary Arterial Hypertension PAH | Phase 1 | Status: RECRUITING